eScholarshipmetadata only
Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy
32 biomedical and clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), immunization (rcdc), childhood leukemia (rcdc), pediatric cancer (rcdc), cancer (rcdc), hematology (rcdc), pediatric research initiative (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1065580
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.